FIELD: organic chemistry, steroids, pharmacy. SUBSTANCE: invention relates to steroid compound of the general formula (I) where means =O, -OH, OR or OOCR where R means alkyl group with from 1 to 6 carbon atoms; R6 means H or where m = 1 or 2; R7 means H, C1-4- alkyl, C2-4- alkenyl or C2-4- alkynyl; R11 means H, C1-4- alkyl, C2-4- alkenyl, C2-4- alkynyl; E means (with exception of carbon atoms 16 and 17 of ring D) 4-7-membered hydrocarbon ring where indicated ring is at α- position with respect to ring D substituted with the group RE, and comprises optionally one endocyclic double bond; RE means H, C1-5 alkyl, C2-5- alkenyl, C2-5- alkynyl, C1-5- alkylidene, -(CH2)n-N3 or -(CH2)n where n = 1 or 2 and where alkyl group can be substituted for OR, -OOCR where R is alkyl with 1-6 carbon atoms; R17 means OH, -OR or OOCR where R means alkyl with 1-6 carbon atoms where indicated steroid compound can involve but optionally a single double bond, Δ5(10), Δ4(5) either ring A can be aromatic. The invention relates to also a pharmaceutical composition comprising the indicated steroid compound. Steroid compounds of the invention shows very high effectiveness for prophylaxis or treatment of disorders associated with per- or post menopause and, more preferably, for prophylaxis or treatment of osteoporosis. Except for, steroid compounds of the invention can be used as contraceptive agents. EFFECT: improved method of synthesis, valuable medicinal properties of steroid compound. 10 cl, 1 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
STEROID COMPOUNDS, METHOD FOR SELECTIVE MODIFICATION, PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2255090C2 |
DERIVATIVE OF 11-(PHENYL-SUBSTITUTED)-ESTRA-4,9-DIENE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2135514C1 |
DERIVATIVES OF 16-HYDROXY-11-(SUBSTITUTED PHENYL)-ESTRA-4,9-DIENE, COMPOUND, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2187510C2 |
STEROID WITH 17-SPIROMETHYLENELACTONE GROUP AND METHOD OF ITS SYNTHESIS | 1995 |
|
RU2168516C2 |
NONAROMATIC ESTROGENIC STEROID, PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2245886C2 |
ACTIVE COMPONENT OF MEDICINAL PREPARATION, STEROID, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2172740C2 |
3-METHYLENE-STEROID DERIVATIVES, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT | 2000 |
|
RU2248358C2 |
SERINE PROTEASE INHIBITORS | 1997 |
|
RU2178419C2 |
COMPOUNDS, SET, ANDROGENIC COMPOSITION | 2000 |
|
RU2242479C2 |
SERINE PROTEASE INHIBITORS | 1997 |
|
RU2172321C2 |
Authors
Dates
2002-05-10—Published
1998-02-20—Filed